SCHEMBL9364666

SCHEMBL9364666

CCC(=O)C(=O)Nc1cc(C(F)(F)F)ccc1[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.53
AKR1C4 P17516 1/20 0.53
AKR1C3 P42330 1/20 0.53
AKR1C2 P52895 1/20 0.53
AKR1C1 Q04828 1/20 0.53
ALDH1A1 P00352 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C19 P33261 2/20 0.49
PKM P14618 2/20 0.48
HPD P32754 1/20 0.48
MAPT P10636 2/20 0.47
KCNMA1 Q12791 1/20 0.46
MAPK1 P28482 3/20 0.46
THRB P10828 2/20 0.45
STAT3 P40763 1/20 0.45
GAA P10253 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9364653 0.90 KCNMA1 (0.58) AKR1B1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL9364671 0.85 GPR35 (0.60) AKR1B1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL8139482 0.82 TDP1 (0.46) ALDH1A1MEN1KMT2APKMMAPT
SCHEMBL9365470 0.81 MAPT (0.54) ALDH1A1KMT2ACYP1A2CYP3A4MAPT
SCHEMBL9365562 0.80 L3MBTL1 (0.59) ALDH1A1PKMMAPTMAPK1
SCHEMBL116789 0.79 MAPT (0.53) AKR1B1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL9365430 0.78 GPR35 (0.45) ALDH1A1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL9364712 0.77 SMN1; SMN2 (0.67) AKR1B1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL117562 0.77 AKR1B1 (0.56) AKR1B1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL8903432 0.77 AR (0.41) ALDH1A1MEN1KMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed